Life Style and Outcome Assessment of Radiofrequency Versus Endovenous Laser Ablation in Management of Varicose Veins, a Comparative Study | ||
| The Egyptian Journal of Surgery | ||
| Volume 44, Issue 4, October 2025, Pages 1137-1145 PDF (450.41 K) | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejsur.2025.361905.1398 | ||
| Authors | ||
| Ahmed Gamil Abdellattif* 1; Mohamed Ragheb Abdelhafeez2; Ayman Abdelhamid Salem3; Khaled Shawky4 | ||
| 1Departments of General and Vascular Surgery, Faculty of Medicine, Cairo University, Egypt | ||
| 2Vascular Surgery, Maadi Armed Forces Hospitals, Egypt | ||
| 3Departments of Vascular Surgery, Faculty of Medicine, Zagazig University, Egypt | ||
| 4Departments of Vascular Surgery, Faculty of Medicine, Beni-suef University, Egypt | ||
| Abstract | ||
| Introduction: The lower limbs are frequently affected by varicose veins (VVs), which are dilated, convoluted veins. In order to manage VVs, conventional surgery proved difficult, and endovenous procedures like radiofrequency ablation (RFA) and endovenous laser ablation (EVLA) have lately taken its place. Objective: This study investigated the effects of RFA compared with EVLA in treating VVs in terms of patient satisfaction and postoperative complications. Methods: Seventy patients with lower limb primary VV were enrolled in this multicenter interventional prospective randomised controlled trial, which took place at three tertiary institutions between January and September of 2023. Two groups—the RFA group and the EVLA group—were randomly assigned to each patient. Post-operative conditions were estimated using the Villata score, and post-operative success, complications, and recurrence were evaluated. Results: The average age of the cases in the RFA group and EVLA groups was 36.51±7.25 and 37.63±7.48 years, respectively. Hyperpigmentation showed a significantly higher level in the RFA group. Both groups had almost the same immediate and delayed success rate, between 96% and 98%. Recurrence rates during follow-up showed no statistically significant difference. The overall Villalta score, as well as its domains and pain distributions among the study participants, did not show a significant difference between the RFA and the EVLA, where both groups show significant enhancement. Conclusion: RFA and LA improve pain and life quality similarly in patients with VVs, making them a first choice in treating primary varicose veins. | ||
| Keywords | ||
| Endovenous laser ablation; radiofrequency; varicose veins; villalta | ||
|
Statistics Article View: 20 PDF Download: 14 |
||
